✦ LIBER ✦

A comparison of relapsed and non-relapsed abstinent pathological gamblers following behavioural treatment

✍ Scribed by A. BLASZCZYNSKI; N. McCONAGHY; A. FRANKOVA

Book ID: 108593820
Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 291 KB
Volume: 86
Category: Article
ISSN: 0965-2140
DOI: 10.1111/j.1360-0443.1991.tb01734.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment Goal Selection for Female Path

Treatment Goal Selection for Female Pathological Gambling: A Comparison of Abstinence and Controlled Gambling

✍ Nicki Dowling; David Smith 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 165 KB

Newly diagnosed versus relapsed idiopath

Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment

✍ Alberto Alvarez-Larrán; Julio del Río-Garma; Misericòrdia Pujol; Javier de la Ru 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 118 KB

Cladribine in the treatment of advanced

Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma

✍ Anil Tulpule; Gary Schiller; Laura A. Harvey-Buchanan; Myung Lee; Byron M. Espin 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

## BACKGROUND. Cladribine (2-chlorodeoxyadenosine) is a purine nucleoside analog with cytotoxic activity against both resting and proliferating cells. Clinical studies with cladribine have reported antitumor activity against various hematologic malignancies.

Failure of IMVP-16 as second-line treatm

Failure of IMVP-16 as second-line treatment for relapsed or refractory high grade non-hodgkin's lymphoma

✍ C. De Lord; A. C. Newland; D. C. Linch; B. Vaughan Hudson; G. Vaughan Hudson 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 283 KB

The British National Lymphoma Investigation (BNLI) has assessed the use of an IMVP-16 regimen (ifosfamide, methotrexate, VP-16) in 46 patients with high grade non-Hodgkin's lymphoma (NHL) who on firstline chemotherapy either failed to attain a complete remission or relapsed. Seventeen patients respo

Modelling cost-effectiveness of high-dos

Modelling cost-effectiveness of high-dose chemotherapy as treatment for relapsed aggressive non-Hodgkin lymphoma in an Australian setting

✍ J. Prajogo; A. Neil; J. Duke; H. Zhang; B. Stokes; P. Rowlings 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 196 KB

Treatment of relapsed or refractory Hodg

Treatment of relapsed or refractory Hodgkin disease and non-Hodgkin lymphoma with high-dose chemoradiotherapy followed by unstimulated autologous peripheral stem cell rescue

✍ Dr. Aaron P. Rapoport; Jacob M. Rowe; Joanna M. Heal; Martin A. Tanner; John F. 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 644 KB